Psoas and Mediastinal Abscesses during Intravenous Tocilizumab Treatment in Multicentric Castleman Disease

Tocilizumab has been used to treat idiopathic multicentric Castleman disease (iMCD). As tocilizumab prevents interleukin-6 from exerting pro-inflammatory effects, there is some concern about a delayed diagnosis of severe infections during tocilizumab treatment. Although serious infections during toc...

Descripción completa

Detalles Bibliográficos
Autores principales: Togitani, Kazuto, Ogasawara, Fumiya, Arakawa, Yu, Sugimura, Natsuki, Miyazaki, Ryohei, Kojima, Kensuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970794/
https://www.ncbi.nlm.nih.gov/pubmed/35732449
http://dx.doi.org/10.2169/internalmedicine.9519-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970794/
https://www.ncbi.nlm.nih.gov/pubmed/35732449
http://dx.doi.org/10.2169/internalmedicine.9519-22

Ejemplares similares